Agree! Wants BP has enough data to know they can at least recoup their investment a $$$$ deal can happen. So if at 2nd lookin they unblinded the trial and it becomes obvious bavi will be approved(especially in the hands of a BP) a deal can happen. They get bavi for 2nd line, off label plus BBs, imaging and anything else is gravy.
This is not pphm of old if 2nd line shows data that screams approval.